Ashley Hall Structure Therapeutics Inc. (GPCR) insider trading activity

GPCR Quotes by TradingView
Shares Held (Direct Ownership) 112K
0% 3M change
66.91% 12M change
Total Value Held N/A

Ashley Hall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 18 2025
SELL
Payment of exercise price or tax liability
$46,602 $7.74 p/Share
6,021 Reduced 5.09%
112,317 Ordinary Shares
Mar 15 2025
BUY
Grant, award, or other acquisition
-
51,048 Added 30.14%
118,338 Ordinary Shares
Sep 18 2024
BUY
Grant, award, or other acquisition
-
67,290 Added 50.0%
67,290 Ordinary Shares

Also insider at

ESPR
Esperion Therapeutics, Inc. Healthcare
Chief Development Officer
RPHM
Reneo Pharmaceuticals, Inc. Healthcare
Chief Development Officer
AH

Ashley Hall

Chief Development Officer
Ann Arbor, MI

Track Institutional and Insider Activities on GPCR

Follow Structure Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GPCR shares.

Notify only if

Insider Trading

Get notified when an Structure Therapeutics Inc. insider buys or sells GPCR shares.

Notify only if

News

Receive news related to Structure Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GPCR